ECR News: Bracco, Dynamic Imaging

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

At ECR 2007 in Vienna, Austria, contrast imaging media provider Bracco demonstrated a number of its imaging agent products, including:

  • Iopamidol, the first commercially available, ready-to-use, non-ionic, water-soluble radiographic (x-ray) contrast agent;
  • Iomeron, a tri-iodinated non-ionic, water-soluble X-ray contrast agent with solutions at the highest concentration of iodine available on the marketplace (400 mgl/mL). The use of x-ray contrast solutions at high concentration of iodine, such as Iopamidol 370 (370 mgI/mL) and Iomeron 400 (400 mgI/mL)  can help to obtain better contrast enhancement than solutions at lower iodine strength when injected at the same flow rate for multidetector computed tomography (MDCT) exams, Bracco said;
  • MultiHance (gadobenate dimeglumine, or Gd-BOPTA), a contrast agent for MRI with a weak and highly reversible protein interaction that can increase relaxivity and improve contrast enhancement on MR images;
  • ProHance (gadoteridol), an MRI contrast agent for imaging the brain, spine and surrounding tissues to improve visualization of lesions with abnormal vascularity, including primary and metastatic tumors; and
  • SonoVue (sulphur hexafluoride) is an innovative contrast agent for ultrasound, launched in October 2001 and now available in all European countries, Switzerland and China. SonoVue is approved for left ventricle endocardial border delineation at rest and during stress, transcranial, extracranial carotid, pheripheral vessels assessment, improvement of normal liver tissue and lesion vascularization, improvement of normal breast tissue and lesion vascularization. The combination of SonoVue with new contrast specific imaging technologies gave rise to a new imaging modality called “Contrast-Enhanced UltraSound (CEUS).

Dynamic Imaging highlighted the implementation of its IntegradWeb PACS throughout the Assuta Medical Centers (Assuta) system in Israel at ECR 2007. Owned by Maccabi Healthcare Services, the second-largest healthcare group in Israel, Assuta operates five hospitals and four outpatient imaging centers. In addition to its flagship Assuta Medical Center in Tel-Aviv (Israel’s largest private hospital), IntegradWeb PACS will be installed at Assuta Hospital in Petah-Tikva and additional facilities in Beer Sheva, Rishon Le Zion, and Haifa. The system also will serve Hashalom Imaging Center in Ampa Tel-Aviv and other imaging and outpatient centers in Ashdod, Ramat-Gan, and Ashkelon. Hundreds of thousands of imaging studies are annually processed through Assuta’s acute care and ambulatory centers. Assuta will implement the following applications: IntegradWeb MAMMO, a digital mammography solution; and OrthoTools, powered by Orthocrat’s TraumaCad orthopedic templating and surgical planning software; and along with other vendor systems and data.